scholarly journals Edemas of the face and lymphoscintigraphic examination

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Pierre Bourgeois ◽  
E. Peters ◽  
A. Van Mieghem ◽  
A. Vrancken ◽  
G. Giacalone ◽  
...  

AbstractFacial edemas not secondary to surgery and/or radiotherapy for head and neck cancer are relatively uncommon. Our aim is to report a retrospective analysis of the lymphoscintigraphic and SPECT-CT investigations obtained in patients with such facial edema. Retrospective review of exams (planar imagings in all and with SPECT-CT in 5) obtained after the subcutaneous injection of 99mTc HSA Nanosized colloids between the eyebrows in five men and seven women. Four main lymphatic pathways were identified on sequential planar imagings: para-nasal left and right and supra- ocular left and right. For eleven patients, the absence of visualization of lymphatic drainage and/or their delayed appearance correlated well with the localisation of the edematous areas. In two patients with post-traumatic and post- surgical edemas, SPECT-CT showed one deep left sided cervical lymph node (LN) in front of the first cervical vertebra. This lymphoscintigraphic approach represents a simple and valuable way to assess the lymphatic drainage pathways of the face and to establish the diagnosis of facial lymphedema.

Toukeibu Gan ◽  
2010 ◽  
Vol 36 (3) ◽  
pp. 349-353
Author(s):  
Shin Rin ◽  
Tetsuro Yamashita ◽  
Michihiro Ueda ◽  
Yuichiro Asaka ◽  
Yoritoshi Nakajima ◽  
...  

2019 ◽  
Vol 46 (6) ◽  
pp. 889-895 ◽  
Author(s):  
Naoki Nishio ◽  
Yasushi Fujimoto ◽  
Mariko Hiramatsu ◽  
Takashi Maruo ◽  
Hidenori Tsuzuki ◽  
...  

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. e17020-e17020
Author(s):  
K. Mitsudo ◽  
T. Shigetomi ◽  
H. Nishiguchi ◽  
T. Fukui ◽  
N. Yamamoto ◽  
...  

e17020 Background: Superselective intra-arterial chemotherapy via a superficial temporal artery (HFT method) has become feasible for daily concurrent radiotherapy and chemotherapy for head and neck cancer. We used this novel method for head and neck cancer, and evaluated its efficacy. Treatment consisted of superselective intra-arterial infusions (docetaxel total 60 mg/m2, cisplatin total 100 mg/m2) and concurrent radiotherapy (total 40 Gy) for 4 weeks as preoperative therapy. Thirty-five patients with stage III and IV oral cancer underwent surgery after this treatment, of whom pathological complete response (CR) was obtained in 31 (88.6%). In this study, the possibility of organ preservation in cases of advanced head and neck cancer was evaluated based on this result. Methods: Eligibility included T3 or T4 squamous cell carcinoma of head and neck. Treatment consisted of superselective intra-arterial infusions (docetaxel, total 60 mg/m2, cisplatin, total 150 mg/m2) and concurrent radiotherapy (total 60 Gy) for 6 weeks. Organ preservation was demonstrated in cases when the biopsy specimen of the primary lesion showed grade 3 (non-viable tumor cells present) or grade 4 (no tumor cells present) after the completion of all treatments. Results: Thirty two patients (21 male and 11 female) were eligible for evaluation. A relapse was detected in 11 cases (34.4%): primary sites, 7 cases (21.9%); cervical lymph node and distant metastasis, 2 cases (6.3%); primary site and distant metastasis, 1 case (3.1%); cervical lymph node, 1 case (3.1%). Seven patients (21.9%) died. The Kaplan-Meier method was used to estimate the 3-year and 5-year survival rates, which were 81.3% and 78.1%, respectively, and the 3-year and 5-year locoregional control rates, which were 68.8% and 64.5%, respectively. No major complications such as cerebral infarctions or other neurological complications developed in any patient. Conclusions: These results of the present study demonstrate that this is a promising new treatment strategy for advanced head and neck cancer, thus contributing to patients’ QOL. No significant financial relationships to disclose.


Sign in / Sign up

Export Citation Format

Share Document